NY S06084 | 2023-2024 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on March 28 2023 - 25% progression, died in committee
Action: 2024-05-09 - PRINT NUMBER 6084B
Pending: Senate Consumer Affairs and Protection Committee
Text: Latest bill text (Amended) [HTML]

Summary

Prohibits the knowing sale of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prohibits the knowing sale of xylazine to persons under the age of 21 and without proof of the intended use for institutional, veterinary, or scientific purposes.

Sponsors


History

DateChamberAction
2024-05-09SenatePRINT NUMBER 6084B
2024-05-09SenateAMEND AND RECOMMIT TO CONSUMER PROTECTION
2024-01-03SenateREFERRED TO CONSUMER PROTECTION
2023-05-24SenatePRINT NUMBER 6084A
2023-05-24SenateAMEND AND RECOMMIT TO CONSUMER PROTECTION
2023-03-28SenateREFERRED TO CONSUMER PROTECTION

Same As/Similar To

A06506 (Same As) 2024-05-28 - RECOMMITTED TO CONSUMER PROTECTION

New York State Sources


Bill Comments

feedback